Potential interactions between prescription drugs and complementary and alternative medicines among patients in the emergency department

Pharmacotherapy
David McD TaylorLufee Wong

Abstract

To determine the nature and prevalence of potential interactions between prescription drugs and complementary and alternative medicines (CAMs) and the reasons some patients do not advise their physicians of CAM use. Cross-sectional survey. The emergency department of the Royal Melbourne Hospital, a tertiary referral center. Four hundred four adult patients (>or= 18 yrs) who visited the emergency department between February 1, 2002, and March 31, 2003. Intervention. A specifically designed, self-administered questionnaire, available in seven languages. Main outcome measures were the prevalence of potential prescription drug-CAM interactions and the reasons some patients do not advise their physicians of CAM use. Mean +/- SD patient age was 50.6 +/- 20.0 years; 220 patients were men (54.5%, 95% confidence interval [CI] 49.5-59.4%). When asked about use during the previous year, 275 patients (68.1%, 95% CI 63.2-72.5%) reported having taken a CAM; of these, 138 were also taking a prescription drug. We identified 15 documented potential drug-CAM interactions in nine patients (3.3% of CAM users, 95% CI 1.6-6.3%) and 97 theoretical potential drug-CAM interactions in 51 patients (18.6% of CAM users, 95% CI 14.2-23.8%). Aspirin and warf...Continue Reading

References

May 13, 1985·The Medical Journal of Australia·W J DonnellyY H Thong
Mar 1, 1997·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·O L HungL R Goldfrank
May 19, 1997·The Medical Journal of Australia·A K Drew, S P Myers
May 30, 1998·JAMA : the Journal of the American Medical Association·J A Astin
Feb 26, 2000·Annals of Emergency Medicine·J Gulla, A J Singer
Jan 3, 2001·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·S J WeissA A Ernst
Mar 12, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Gayle Nicholas Scott, Gary W Elmer
Apr 17, 2002·Annals of Internal Medicine·Michael H Cohen, David M Eisenberg
Aug 30, 2002·Preventive Medicine·Alastair H MacLennanAnne W Taylor
Jun 4, 2004·The Medical Journal of Australia·George T Lewith, Alan Bensoussan
Jun 18, 2004·The Medical Journal of Australia·Marc M Cohen
Sep 7, 2004·The Medical Journal of Australia·David Owen, George T Lewith
Sep 21, 2004·The Medical Journal of Australia·Alan Bensoussan, George T Lewith
Nov 13, 2004·Emergency Medicine Australasia : EMA·David McD TaylorLuFee Wong
Jun 25, 2005·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·Jeff DeSimone

❮ Previous
Next ❯

Citations

Mar 2, 2011·Journal of Thrombosis and Thrombolysis·Edith NutescuErika Hellenbart
Apr 25, 2009·The Nurse Practitioner·Susan Simmons Holcomb
Jul 6, 2010·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Kyrillos Guirguis
Dec 10, 2013·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Tracy Trail-MahanKaren Bawel-Brinkley
Sep 24, 2011·Medicina clínica·José Ramón Vallejo, Diego Peral
Nov 26, 2015·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Hong Jung WooEungyeong Jang
Apr 16, 2015·Journal of Paediatrics and Child Health·David McDonald TaylorFranz E Babl
Aug 9, 2016·Research in Social & Administrative Pharmacy : RSAP·Mohamed Azmi HassaliOmar Thanoon Dawood
Jan 30, 2018·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ashleigh J SellarJonathan C Knott
Nov 30, 2019·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Anthony ArmsonBruce Walker
Nov 2, 2020·BMC Complementary Medicine and Therapies·Jenny M CarlssonKristofer Bjerså
May 8, 2020·Complementary Therapies in Clinical Practice·Joel AlcantaraJunjoe Alcantara
Jun 13, 2020·Pediatric Emergency Care·Jayapriya SathiyanSashikumar Ganapathy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Eric AntignacHervé Toutain
British Journal of Clinical Pharmacology
Peter A G M De Smet
© 2022 Meta ULC. All rights reserved